Jessica Chubak, PhD

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Jessica.Chubak@kp.org
206-287-2556
Animal-assisted interactions research on Facebook

Curriculum vitae (CV)

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

Cancer

Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Health Services & Economics

Screening
Medication Use & Patient Safety

Cancer risk and use of common medications

Recent publications

Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient reported discontinuation of endocrine therapy and related side effects among women with early stage breast cancer. J Oncol Prac. Nov 1 2012:e149-57. PubMed

Laing S, Bogart A, Green B, Chubak J. Ps2-22: Exploring the course of psychological distress and perceived health status after receiving a positive fecal occult blood test result. Clin Med Res. 2012;10(3):181-2. PubMed

Henderson JA, Chubak J, O’Connell J, Ramos MC, Jensen J, Jobe, JB. Design of a randomized controlled trial of a web-based intervention to reduce cardiovascular disease risk factors among remote-dwelling American Indians. J Prim Prev. 2012 Aug;33(4):209-22. PubMed

Chubak J, Anderson ML, Saunders KW, Hubbard RA, Tuzzio L, Liss DT, Morales LS, Reid RJ. Predictors of 1-year change in patient activation among older adults with diabetes and heart disease. J Am Geriatr Soc. 2012 Jul;60(7):1316-21. doi: 10.1111/j.1532-5415.2012.04008.x. PubMed

Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, Ulcickas Yood M, Barlow WE, Buist DS. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012 Jun 20;104(12):931-40. Epub 2012 Apr 30. PubMed

Pocobelli G, Chubak J, Hanson N, Drescher C, Resta R, Urban N, Buist DS. Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling. Gynecol Oncol. 2012 Aug;126(2):229-35. Epub 2012 May 4. PubMed

Aiello Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 through 2008 varies by age of breast cancer diagnosis and tumor size. J Oncol Pract. 2012;8(2):113-20. PubMed